sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Global Influenza Treatment Market Size study & Forecast, by Treatment by Route of Administration, by Distribution Channel and Regional Analysis, 2023-2030

Global Influenza Treatment Market Size study & Forecast, by Treatment...

Home / Categories / Healthcare
Global Influenza Treatment Market Size study & Forecast, by Treatment by Route of Administration, by Distribution Channel and Regional Analysis, 2023-2030
Global Influenza Treatment Market Size...
Report Code
RO1/103/3130

Publish Date
26/Sep/2024

Pages
200
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Influenza Treatment Market, by region, 2020-2030 (USD Billion)
1.2.2. Influenza Treatment Market, by Treatment, 2020-2030 (USD Billion)
1.2.3. Influenza Treatment Market, by Route of Administration, 2020-2030 (USD Billion)
1.2.4. Influenza Treatment Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Influenza Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Influenza Treatment Market Dynamics
3.1. Influenza Treatment Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increased prevalence of contagious respiratory illness
3.1.1.2. Emerging prevalence of seasonal flu
3.1.1.3. Rising drug approval activities
3.1.2. Market Challenges
3.1.2.1. High Cost of Influenza Treatment
3.1.2.2. Stringent regulatory processes and delays in drug approvals
3.1.3. Market Opportunities
3.1.3.1. Rising investment in research and development activities
3.1.3.2. Increased public awareness about the severity of influenza
Chapter 4. Global Influenza Treatment Market: Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economic
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Influenza Treatment Market, by Treatment
5.1. Market Snapshot
5.2. Global Influenza Treatment Market by Treatment, Performance - Potential Analysis
5.3. Global Influenza Treatment Market Estimates & Forecasts by Treatment 2020-2030 (USD Billion)
5.4. Influenza Treatment Market, Sub Segment Analysis
5.4.1. Peramivir
5.4.2. Zanamivir
5.4.3. Baloxavir Marboxil
5.4.4. Oseltamivir Phosphate
5.4.5. Others
Chapter 6. Global Influenza Treatment Market, by Route of Administration
6.1. Market Snapshot
6.2. Global Influenza Treatment Market by Route of Administration, Performance - Potential Analysis
6.3. Global Influenza Treatment Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
6.4. Influenza Treatment Market, Sub Segment Analysis
6.4.1. Oral
6.4.2. Others
Chapter 7. Global Influenza Treatment Market, by Distribution Channel
7.1. Market Snapshot
7.2. Global Influenza Treatment Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Influenza Treatment Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
7.4. Influenza Treatment Market, Sub Segment Analysis
7.4.1. Hospital Pharmacies
7.4.2. Retail Pharmacies
7.4.3. Online Pharmacies
Chapter 8. Global Influenza Treatment Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Influenza Treatment Market, Regional Market Snapshot
8.4. North America Influenza Treatment Market
8.4.1. U.S. Influenza Treatment Market
8.4.1.1. Treatment breakdown estimates & forecasts, 2020-2030
8.4.1.2. Route of Administration breakdown estimates & forecasts, 2020-2030
8.4.1.3. Distribution Channel breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Influenza Treatment Market
8.5. Europe Influenza Treatment Market Snapshot
8.5.1. U.K. Influenza Treatment Market
8.5.2. Germany Influenza Treatment Market
8.5.3. France Influenza Treatment Market
8.5.4. Spain Influenza Treatment Market
8.5.5. Italy Influenza Treatment Market
8.5.6. Rest of Europe Influenza Treatment Market
8.6. Asia-Pacific Influenza Treatment Market Snapshot
8.6.1. China Influenza Treatment Market
8.6.2. India Influenza Treatment Market
8.6.3. Japan Influenza Treatment Market
8.6.4. Australia Influenza Treatment Market
8.6.5. South Korea Influenza Treatment Market
8.6.6. Rest of Asia Pacific Influenza Treatment Market
8.7. Latin America Influenza Treatment Market Snapshot
8.7.1. Brazil Influenza Treatment Market
8.7.2. Mexico Influenza Treatment Market
8.8. Middle East & Africa Influenza Treatment Market
8.8.1. Saudi Arabia Influenza Treatment Market
8.8.2. South Africa Influenza Treatment Market
8.8.3. Rest of Middle East & Africa Influenza Treatment Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. NATCO Pharma Limited
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Novartis AG
9.3.3. F. Hoffmann-La Roche Ltd
9.3.4. BioCryst Pharmaceuticals, Inc.
9.3.5. Sanofi S.A
9.3.6. GSK plc.
9.3.7. Viatris Inc. (MYLAN)
9.3.8. Teva Pharmaceutical Industries Ltd.
9.3.9. Daiichi Sankyo Company, Limited.
9.3.10. AstraZeneca
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com